Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04187365 · ClinicalTrials.gov registry record · NA
Optimizing the Management of Postpartum Urinary Retention
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT04187365: Clinical Trial NA study, sponsored by Northwestern University.
NCT04187365 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04187365, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
A study aimed at characterizing the comparing duration of catheterization for treatment of postpartum urinary retention (PUR) and characterizing short and long-term pelvic floor symptoms in women who have PUR.
Interventions
- OTHER Duration of Indwelling Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-11-22 |
| Est. Completion | 2022-02-27 |
| Phase | NA |
Why NCT04187365 stopped before completion
NCT04187365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Duration of Indwelling Catheter is the first listed.
NCT04187365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04187365 about?
NCT04187365 is a clinical study titled "Optimizing the Management of Postpartum Urinary Retention". A study aimed at characterizing the comparing duration of catheterization for treatment of postpartum urinary retention (PUR) and characterizing short and long-term pelvic floor symptoms in women who have PUR.
What is the current status of trial NCT04187365?
This trial is currently terminated. It is a NA study. The enrollment target is 70 participants. The study started on 2019-11-22. Estimated completion is 2022-02-27.
What interventions are being tested in trial NCT04187365?
The interventions under investigation include: Duration of Indwelling Catheter (OTHER).
Who is sponsoring clinical trial NCT04187365?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04187365's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI